Ads

 

Ads

 

Ads

 

World Top 100 Pharmaceutical Companies List by Market Cap in January 2024

World Top 100 Pharmaceutical Companies List by Market Cap in January 2024, World Biggest 100 Pharmaceutical Companies by Market Cap, World Largest 100 Pharmaceutical Companies in the World by market cap as pf Jan-05-2024.

Metatag Title
World Top Pharmaceutical Companies in 2024
Metatag Abstract
World Top Pharmaceutical Companies by Market Cap in 2024, World Largest Pharmaceutical Companies by Market Cap in 2024.
  1. Shanghai Industrial Holdings

    World Rank (Jan-05-2024)
    7,117
    Market Cap (Jan-05-2024)
    1.385 Billion USD
    World Rank (Jul-30-2023)
    6,496
    Market Cap (Jul-30-2023)
    1.639 Billion USD
    World Rank (Dec-25-2022)
    7,040
    Market Cap (Dec-25-2022)
    1.344 Billion USD
    World Rank (Jan-07-2022)
    7,134
    Market Cap (Jan-07-2022)
    1.62 Billion USD
    Annual Revenue in USD
    4,938 Million USD
    Annual Net Income in USD
    475 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Shanghai Industrial Holdings is a conglomerate company with three core businesses and they are infrastructure facilities (including toll roads/bridge, and environmental protection related business such as sewage treatment and solid waste treatment business), real estate and consumer products (including Nanyang Tobacco and Wing Fat Printing). The company annual revenue is 38,747 million HKD and annual net income is 3,745 million HKD for year ending Dec-2021. The headquarters is in Hong Kong.
  2. Mirum Pharmaceuticals

    World Rank (Jan-05-2024)
    7,121
    Market Cap (Jan-05-2024)
    1.384 Billion USD
    World Rank (Jul-30-2023)
    8,800
    Market Cap (Jul-30-2023)
    0.988 Billion USD
    World Rank (Dec-25-2022)
    10,559
    Market Cap (Dec-25-2022)
    0.673 Billion USD
    World Rank (Jan-07-2022)
    13,731
    Market Cap (Jan-07-2022)
    0.48 Billion USD
    Annual Revenue in USD
    77 Million USD
    Annual Operating Income in USD
    -131 Million USD
    Annual Net Income in USD
    -135 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Mirum Pharmaceuticals is a Clinical Stage Biopharmaceutical company focused on clinical studies for the treatment of cholestatic diseases including primary sclerosing cholangitis (PSC), intrahepatic cholestasis of pregnancy (ICP) and primary biliary cholangitis (PBC). It is having 24 employees as on 2019. The headquarters is in USA.
  3. Xiamen Kingdomway Group Company

    World Rank (Jan-05-2024)
    7,140
    Market Cap (Jan-05-2024)
    1.377 Billion USD
    World Rank (Jul-30-2023)
    6,492
    Market Cap (Jul-30-2023)
    1.640 Billion USD
    World Rank (Dec-25-2022)
    6,296
    Market Cap (Dec-25-2022)
    1.598 Billion USD
    World Rank (Jan-07-2022)
    4,846
    Market Cap (Jan-07-2022)
    3.00 Billion USD
    Annual Revenue in USD
    526 Million USD
    Annual Net Income in USD
    115 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
  4. Avadel Pharmaceuticals

    World Rank (Jan-05-2024)
    7,226
    Market Cap (Jan-05-2024)
    1.350 Billion USD
    World Rank (Jul-30-2023)
    8,305
    Market Cap (Jul-30-2023)
    1.092 Billion USD
    World Rank (Dec-25-2022)
    13,348
    Market Cap (Dec-25-2022)
    0.434 Billion USD
    World Rank (Jan-07-2022)
    14,705
    Market Cap (Jan-07-2022)
    0.41 Billion USD
    Annual Revenue in USD
    22 Million USD
    Annual Net Income in USD
    7 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
  5. Fagron NV

    World Rank (Jan-05-2024)
    7,254
    Market Cap (Jan-05-2024)
    1.341 Billion USD
    World Rank (Jul-30-2023)
    7,463
    Market Cap (Jul-30-2023)
    1.302 Billion USD
    World Rank (Dec-25-2022)
    8,314
    Market Cap (Dec-25-2022)
    1.012 Billion USD
    World Rank (Jan-07-2022)
    8,277
    Market Cap (Jan-07-2022)
    1.25 Billion USD
    Annual Revenue in USD
    573 Million USD
    Annual Net Income in USD
    61 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Fagron NV is a pharmaceutical compounding company focused on medical conference bringing together international experts in plastic surgery, dermatology and aesthetic science. The company annual revenue is 555.9 million EUR, annual net income is 59.6 million EUR and total assets are 752.8 million EUR as on 2020. The headquarters is in Belgium.
  6. Agios Pharmaceuticals

    World Rank (Jan-05-2024)
    7,260
    Market Cap (Jan-05-2024)
    1.340 Billion USD
    World Rank (Jul-30-2023)
    6,950
    Market Cap (Jul-30-2023)
    1.477 Billion USD
    World Rank (Dec-25-2022)
    6,594
    Market Cap (Dec-25-2022)
    1.485 Billion USD
    World Rank (Jan-07-2022)
    6,755
    Market Cap (Jan-07-2022)
    1.77 Billion USD
    Annual Revenue in USD
    14 Million USD
    Annual Operating Income in USD
    -389 Million USD
    Annual Net Income in USD
    -231 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Bio-pharmaceutical company with headquarters is in Massachusetts, USA.
  7. Sumitomo Pharma Co. Ltd

    World Rank (Jan-05-2024)
    7,290
    Market Cap (Jan-05-2024)
    1.330 Billion USD
    World Rank (Jul-30-2023)
    6,035
    Market Cap (Jul-30-2023)
    1.845 Billion USD
    World Rank (Dec-25-2022)
    4,078
    Market Cap (Dec-25-2022)
    2.998 Billion USD
    World Rank (Jan-07-2022)
    3,494
    Market Cap (Jan-07-2022)
    4.62 Billion USD
    Annual Revenue in USD
    4,087 Million USD
    Annual Net Income in USD
    412 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Sumitomo Dainippon Pharma is a Pharmaceutical company. It manufactures and sales pharmaceuticals, food ingredients, food additives, veterinary medicines and others. The company has market capitalization is 22.4 billion yen and has around 3,074 employees on standalone basis and has 6,646 employees on consolidated basis as on December 2020. The headquarters is in Japan.

    SUMITOMO DAINIPPON PHARMA was renamed to SUMITOMO PHARMA CO., LTD in April-2022.

  8. North China Pharmaceutical Company. Ltd

    World Rank (Jan-05-2024)
    7,291
    Market Cap (Jan-05-2024)
    1.330 Billion USD
    World Rank (Jul-30-2023)
    7,218
    Market Cap (Jul-30-2023)
    1.385 Billion USD
    World Rank (Dec-25-2022)
    6,099
    Market Cap (Dec-25-2022)
    1.668 Billion USD
    World Rank (Jan-07-2022)
    4,688
    Market Cap (Jan-07-2022)
    3.14 Billion USD
    Annual Revenue in USD
    975 Million USD
    Annual Net Income in USD
    3 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
  9. Vetoquinol SA

    World Rank (Jan-05-2024)
    7,306
    Market Cap (Jan-05-2024)
    1.324 Billion USD
    World Rank (Jul-30-2023)
    7,744
    Market Cap (Jul-30-2023)
    1.224 Billion USD
    World Rank (Dec-25-2022)
    7,941
    Market Cap (Dec-25-2022)
    1.096 Billion USD
    World Rank (Jan-07-2022)
    6,843
    Market Cap (Jan-07-2022)
    1.74 Billion USD
    Annual Revenue in USD
    594 Million USD
    Annual Operating Income in USD
    93 Million USD
    Annual Net Income in USD
    53 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
  10. BioCryst Pharmaceuticals

    World Rank (Jan-05-2024)
    7,310
    Market Cap (Jan-05-2024)
    1.323 Billion USD
    World Rank (Jul-30-2023)
    7,021
    Market Cap (Jul-30-2023)
    1.451 Billion USD
    World Rank (Dec-25-2022)
    5,228
    Market Cap (Dec-25-2022)
    2.135 Billion USD
    World Rank (Jan-07-2022)
    6,134
    Market Cap (Jan-07-2022)
    2.08 Billion USD
    Annual Revenue in USD
    270 Million USD
    Annual Operating Income in USD
    -148 Million USD
    Annual Net Income in USD
    -247 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    BioCryst Pharmaceuticals is a Biotechnology company designs and develops small molecule medicines for rare diseases like hereditary angioedema (HAE) and fibrodysplasia ossificans progressive (FOP). The company annual revenue is 49 million USD and 140 employees as on 2019. The headquarters is in USA.

Share

Ads